Search Results 1231-1240 of 21035 for magnesiummagnesium

  1. Axitinib (oral route) - Mayo Clinic

    For kidney cancer (axitinib with avelumab):. Adults—At first, 5 milligrams (mg) 2 times a day together with avelumab 800 mg every 2 weeks. Your doctor may ...

  2. New treatment option for early type 1 diabetes - Mayo Clinic

    Stage 2: two or more positive diabetes autoantibodies and asymptomatic dysglycemia (fasting glucose, 100-125 mg/dL; two-hour glucose, 140-199 mg/dL; or A1C 5.7% ...

  3. Levoketoconazole (oral route) - Mayo Clinic

    Hypomagnesemia (low levels of magnesium), history of—Use with caution. May ... However, the dose is usually not more than 1200 mg per day (600 mg 2 times a day).

  4. Ixazomib (oral route) - Mayo Clinic

    For oral dosage form (capsules):. For multiple myeloma (in combination with lenalidomide and dexamethasone):. Adults—At first, 4 milligrams (mg) once a week, ...

  5. Tocainide (oral route) - Mayo Clinic

    Then, your doctor may increase your dose up to 600 mg three times a day. Children—Use and dose must be determined by your doctor. Missed Dose. If you miss ...

  6. Methylnaltrexone (subcutaneous route) - Mayo Clinic

    The dose is 12 milligrams (mg) injected under the skin once a day for at least 4 weeks (with narcotic pain medicines). Children—Use and dose must be determined ...

  7. Publications - Clement J. Michet, Jr., M.D. - Mayo Clinic

    1991; 2:58-70. Wilson MG, Michet CJ Jr, Ilstrup DM, Melton LJ 3rd. Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence ...

  8. Ergotamine and caffeine (rectal route) - Mayo Clinic

    Each suppository contains 2 milligrams (mg) ergotamine and 100 mg caffeine. Do not use more than 2 suppositories in a day or 5 suppositories in a week ...

  9. Vandetanib (oral route) - Mayo Clinic

    Hypomagnesemia (low magnesium in the blood)—Use with caution. These ... Adults—300 milligrams (mg) once a day. Your doctor may adjust your dose as ...

  10. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    About this study. The primary objective of the study is to evaluate the effectiveness of depemokimab 200 mg SC every 26 weeks compared with mepolizumab 300 ...